Entera Bio Ltd.
ENTX
$1.96
-$0.02-1.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.66M | -2.57M | -2.36M | -3.02M | -2.15M |
| Total Depreciation and Amortization | 7.00K | 8.00K | 11.00K | 11.00K | 11.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 531.00K | 600.00K | 585.00K | 932.00K | 593.00K |
| Change in Net Operating Assets | 487.00K | 555.00K | 295.00K | -76.00K | 206.00K |
| Cash from Operations | -1.63M | -1.40M | -1.47M | -2.15M | -1.34M |
| Capital Expenditure | -29.00K | -8.00K | -3.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -29.00K | -8.00K | -3.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 24.00K | 13.52M | 3.54M | 13.00K | 1.24M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -75.00K | -186.00K | -323.00K | -- | -19.00K |
| Cash from Financing | -51.00K | 13.34M | 3.22M | 13.00K | 1.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.71M | 11.93M | 1.75M | -2.14M | -119.00K |